Image of the Day: Right on Target
Image of the Day: Right on Target
An injectable biomaterial calls cancer drugs to tumor sites in mice.
Image of the Day: Right on Target
Image of the Day: Right on Target

An injectable biomaterial calls cancer drugs to tumor sites in mice.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

cancer biology
Glioblastoma on a Chip
Glioblastoma on a Chip
Jef Akst | Jul 15, 2019
Researchers use 3-D printing technology to construct a brain cancer model that accurately recapitulated in vivo biology and predicted patient drug responses.
Infographic: A 3-D Printed Brain Tumor
Infographic: A 3-D Printed Brain Tumor
Jef Akst | Jul 15, 2019
How researchers create a glioblastoma on a chip that can predict patients’ response to treatments
T Cell Proliferation Linked to CAR T Responses
T Cell Proliferation Linked to CAR T Responses
Ashley Yeager | Jul 15, 2019
Comparing the cells of cancer patients who did and did not respond to the immunotherapy could reveal biomarkers to predict who should receive it in the first place.
Infographic: Neoantigen Prediction for Personalized Vaccine Design
Infographic: Neoantigen Prediction for Personalized Vaccine Design
Jasreet Hundal, Elaine R. Mardis | Jul 15, 2019
See how a computational pipeline uses next-generation sequencing data to identify genetic alterations that produce cancer-specific antigens.
Infographic: Gut Microbes Change How Well Drugs Work
Infographic: Gut Microbes Change How Well Drugs Work
Shawna Williams | Jul 15, 2019
Our resident bacteria can affect the activity of immunotherapies and other medicines in the body.
Table: Personalized Cancer Vaccine Trials in the United States
Table: Personalized Cancer Vaccine Trials in the United States
Jasreet Hundal, Elaine R. Mardis | Jul 15, 2019
There are currently more than two dozen ongoing Phase 1 and Phase 2 trials using different vaccine platforms such as DNA, RNA, synthetic long peptides, and dendritic cells.
Hematologist and Oncologist Eugene Frenkel Dies
Hematologist and Oncologist Eugene Frenkel Dies
Ashley P. Taylor | Jul 2, 2019
Frenkel investigated drug resistance in cancers and how vitamin B12 deficiency damages neurons.
Dying Cells Push the Mouse Immune System into Killing Tumors
Dying Cells Push the Mouse Immune System into Killing Tumors
Katarina Zimmer | Jun 21, 2019
Introducing either necroptotic cells or an enzyme that triggers necroptosis can wipe out cancer.
Henry Lynch, Leader in Cancer Genetics, Dies
Henry Lynch, Leader in Cancer Genetics, Dies
Chia-Yi Hou | Jun 7, 2019
The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.
欧洲杯竞猜